211 related articles for article (PubMed ID: 24950013)
1. Update on SPECT and PET in parkinsonism - part 1: imaging for differential diagnosis.
Meyer PT; Hellwig S
Curr Opin Neurol; 2014 Aug; 27(4):390-7. PubMed ID: 24950013
[TBL] [Abstract][Full Text] [Related]
2. Update on SPECT and PET in parkinsonism - part 2: biomarker imaging of cognitive impairment in Lewy-body diseases.
Meyer PT; Frings L; Hellwig S
Curr Opin Neurol; 2014 Aug; 27(4):398-404. PubMed ID: 24978635
[TBL] [Abstract][Full Text] [Related]
3. [¹⁸F]FDG-PET is superior to [¹²³I]IBZM-SPECT for the differential diagnosis of parkinsonism.
Hellwig S; Amtage F; Kreft A; Buchert R; Winz OH; Vach W; Spehl TS; Rijntjes M; Hellwig B; Weiller C; Winkler C; Weber WA; Tüscher O; Meyer PT
Neurology; 2012 Sep; 79(13):1314-22. PubMed ID: 22914831
[TBL] [Abstract][Full Text] [Related]
4. Molecular imaging in Parkinsonism: The essential for clinical practice and future perspectives.
Horowitz T; Grimaldi S; Azulay JP; Guedj E
Rev Neurol (Paris); 2022 May; 178(5):484-489. PubMed ID: 35527085
[TBL] [Abstract][Full Text] [Related]
5. [Nuclear medicine imaging in neurodegenerative dementias].
Gratz S; Hahn U; Kaiser JW; Jarnig M; Schwarz J; Förstl H
Dtsch Med Wochenschr; 2008 May; 133 Suppl 1():S5-7. PubMed ID: 18437639
[TBL] [Abstract][Full Text] [Related]
6. Single Photon Emission Computed Tomography/Positron Emission Tomography Molecular Imaging for Parkinsonism: A Fast-Developing Field.
Verger A; Grimaldi S; Ribeiro MJ; Frismand S; Guedj E
Ann Neurol; 2021 Nov; 90(5):711-719. PubMed ID: 34338333
[TBL] [Abstract][Full Text] [Related]
7. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group.
Benamer TS; Patterson J; Grosset DG; Booij J; de Bruin K; van Royen E; Speelman JD; Horstink MH; Sips HJ; Dierckx RA; Versijpt J; Decoo D; Van Der Linden C; Hadley DM; Doder M; Lees AJ; Costa DC; Gacinovic S; Oertel WH; Pogarell O; Hoeffken H; Joseph K; Tatsch K; Schwarz J; Ries V
Mov Disord; 2000 May; 15(3):503-10. PubMed ID: 10830416
[TBL] [Abstract][Full Text] [Related]
8. A comparison of FDG-PET and blood flow SPECT in the diagnosis of neurodegenerative dementias: a systematic review.
Davison CM; O'Brien JT
Int J Geriatr Psychiatry; 2014 Jun; 29(6):551-61. PubMed ID: 24123413
[TBL] [Abstract][Full Text] [Related]
9. [Functional neuroimaging in the diagnosis of patients with Parkinsonism: Update and recommendations for clinical use].
Arbizu J; Luquin MR; Abella J; de la Fuente-Fernández R; Fernandez-Torrón R; García-Solís D; Garrastachu P; Jiménez-Hoyuela JM; Llaneza M; Lomeña F; Lorenzo-Bosquet C; Martí MJ; Martinez-Castrillo JC; Mir P; Mitjavila M; Ruiz-Martínez J; Vela L
Rev Esp Med Nucl Imagen Mol; 2014; 33(4):215-26. PubMed ID: 24731551
[TBL] [Abstract][Full Text] [Related]
10. Regions of interest-based discriminant analysis of DaTSCAN SPECT and FDG-PET for the classification of dementia.
Garibotto V; Montandon ML; Viaud CT; Allaoua M; Assal F; Burkhard PR; Ratib O; Zaidi H
Clin Nucl Med; 2013 Mar; 38(3):e112-7. PubMed ID: 23357822
[TBL] [Abstract][Full Text] [Related]
11. Update on PET in neurodegenerative and neuroinflammatory disorders manifesting on a behavioural level: imaging for differential diagnosis.
Hellwig S; Domschke K; Meyer PT
Curr Opin Neurol; 2019 Aug; 32(4):548-556. PubMed ID: 31107281
[TBL] [Abstract][Full Text] [Related]
12. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
[TBL] [Abstract][Full Text] [Related]
13. Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism.
Feigin A; Antonini A; Fukuda M; De Notaris R; Benti R; Pezzoli G; Mentis MJ; Moeller JR; Eidelberg D
Mov Disord; 2002 Nov; 17(6):1265-70. PubMed ID: 12465066
[TBL] [Abstract][Full Text] [Related]
14. Role of DAT-SPECT in the diagnostic work up of parkinsonism.
Scherfler C; Schwarz J; Antonini A; Grosset D; Valldeoriola F; Marek K; Oertel W; Tolosa E; Lees AJ; Poewe W
Mov Disord; 2007 Jul; 22(9):1229-38. PubMed ID: 17486648
[TBL] [Abstract][Full Text] [Related]
15. Nigrostriatal dopamine terminal imaging with dopamine transporter SPECT: an update.
Tatsch K; Poepperl G
J Nucl Med; 2013 Aug; 54(8):1331-8. PubMed ID: 23864718
[TBL] [Abstract][Full Text] [Related]
16. 123I-MIBG cardiac uptake, smell identification and 123I-FP-CIT SPECT in the differential diagnosis between vascular parkinsonism and Parkinson's disease.
Navarro-Otano J; Gaig C; Muxi A; Lomeña F; Compta Y; Buongiorno MT; Martí MJ; Tolosa E; Valldeoriola F
Parkinsonism Relat Disord; 2014 Feb; 20(2):192-7. PubMed ID: 24252299
[TBL] [Abstract][Full Text] [Related]
17. Dual-tracer dopamine transporter and perfusion SPECT in differential diagnosis of parkinsonism using template-based discriminant analysis.
Van Laere K; Casteels C; De Ceuninck L; Vanbilloen B; Maes A; Mortelmans L; Vandenberghe W; Verbruggen A; Dom R
J Nucl Med; 2006 Mar; 47(3):384-92. PubMed ID: 16513606
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers in dementia with Lewy bodies: a review.
Sinha N; Firbank M; O'Brien JT
Int J Geriatr Psychiatry; 2012 May; 27(5):443-53. PubMed ID: 21721045
[TBL] [Abstract][Full Text] [Related]
19. Complementary role of 18F-FDG PET and 123I-ioflupane SPECT in the diagnosis of Lewy body disease.
Jolepalem P; Balon HR; Wong CY; Wu D
J Nucl Med Technol; 2014 Sep; 42(3):233-4. PubMed ID: 25033885
[TBL] [Abstract][Full Text] [Related]
20. Validation in SPECT imaging on presynaptic dopaminergic deficit for dementia with Lewy bodies and degenerative Parkinsonism.
Kawada T
J Neurol Sci; 2018 Sep; 392():116. PubMed ID: 30055381
[No Abstract] [Full Text] [Related]
[Next] [New Search]
